# Early Identification and Treatment of Rare Cardiomyopathy Cohorts

> **NCT06794710** · NA · NOT_YET_RECRUITING · sponsor: **RenJi Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy (HCM)
- Dilated Cardiomyopathy (DCM)
- Metabolic Cardiomyopathy
- Restrictive Cardiomyopathy

## Interventions

- **DRUG:** diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoids
- **BEHAVIORAL:** Close follow-up
- **BEHAVIORAL:** early rehabilitation guidance

## Key facts

- **NCT ID:** NCT06794710
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06794710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06794710, "Early Identification and Treatment of Rare Cardiomyopathy Cohorts". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06794710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*